• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高抗胆碱能负担与中年女性前一年的跌倒史有关:阿伯丁前瞻性骨质疏松症筛查研究的结果。

A high anticholinergic burden is associated with a history of falls in the previous year in middle-aged women: findings from the Aberdeen Prospective Osteoporosis Screening Study.

机构信息

Ageing Clinical & Experimental Research (ACER) Team, Institute of Applied Health Sciences, School of Medicine, Medical Sciences, and Nutrition, University of Aberdeen, UK; Aberdeen Centre for Arthritis and Musculoskeletal Health, University of Aberdeen, UK.

Aberdeen Centre for Arthritis and Musculoskeletal Health, University of Aberdeen, UK; Arthritis and Musculoskeletal Medicine Research Programme, Institute of Medical Sciences, University of Aberdeen, UK; Medicines Monitoring Unit, University of Dundee, Dundee, UK.

出版信息

Ann Epidemiol. 2018 Aug;28(8):557-562.e2. doi: 10.1016/j.annepidem.2018.05.011. Epub 2018 Jun 2.

DOI:10.1016/j.annepidem.2018.05.011
PMID:29937404
Abstract

PURPOSE

To examine the cross-sectional association between anticholinergic medication burden (ACB) and a history of falls, bone mineral density, and low trauma fractures in middle-aged women aged under 65 years from the Aberdeen Prospective Osteoporosis Screening Study.

METHODS

ACB (0 = none, 1 = possible, ≥2 = definite) was calculated from medication use for 3883 Caucasian women [mean age (SD) = 54.3 (2.3) years] attending the second Aberdeen Prospective Osteoporosis Screening Study visit (1997-2000). Outcomes were examined using logistic regression. Model adjustments were selected a priori based on expert opinion.

RESULTS

Of 3883 participants, 3293 scored ACB = 0, 328 scored ACB = 1, and 262 scored ACB ≥2. High ACB burden (≥2) was associated with increased odds (ACB = 0 reference) for falls (fully adjusted odds ratio [95% confidence intervals] = 1.81 [1.25-2.62]; P = 0.002) and having low bone mineral density (lowest quintile-20%) at Ward's triangle (3.22 [1.30-7.99]; P = 0.01). A history of falls over the year prior to the study visit in participants with ACB score ≥2 was 32 per 100. For ACB categories 1 and 0, a history of falls per 100 was 21 and 22, respectively.

CONCLUSIONS

The risk of falling associated with ACB observed in older age may also extend to middle-aged women.

摘要

目的

在年龄在 65 岁以下的中年女性中,从阿伯丁前瞻性骨质疏松症筛查研究中,研究抗胆碱能药物负担 (ACB) 与跌倒史、骨密度和低创伤性骨折之间的横断面关联。

方法

根据 3883 名参加第二次阿伯丁前瞻性骨质疏松症筛查研究(1997-2000 年)的白种人女性(平均年龄 [标准差] 54.3 [2.3] 岁)使用药物的情况,计算 ACB(0 = 无,1 = 可能,≥2 = 明确)。使用逻辑回归检查结果。根据专家意见,预先选择模型调整。

结果

在 3883 名参与者中,3293 名的 ACB = 0,328 名的 ACB = 1,262 名的 ACB ≥2。高 ACB 负担(≥2)与跌倒的几率增加相关(ACB = 0 参考)(完全调整后的优势比 [95%置信区间] = 1.81 [1.25-2.62];P = 0.002)和在 Ward 三角区的骨密度较低(最低五分位数-20%)(3.22 [1.30-7.99];P = 0.01)。在 ACB 评分≥2 的参与者中,研究前一年有跌倒史的比例为 32 每 100。对于 ACB 类别 1 和 0,每 100 例跌倒的历史分别为 21 和 22。

结论

在老年人群中观察到的与 ACB 相关的跌倒风险可能也会扩展到中年女性。

相似文献

1
A high anticholinergic burden is associated with a history of falls in the previous year in middle-aged women: findings from the Aberdeen Prospective Osteoporosis Screening Study.高抗胆碱能负担与中年女性前一年的跌倒史有关:阿伯丁前瞻性骨质疏松症筛查研究的结果。
Ann Epidemiol. 2018 Aug;28(8):557-562.e2. doi: 10.1016/j.annepidem.2018.05.011. Epub 2018 Jun 2.
2
Anticholinergic burden in middle-aged women and recurrent falls in later life: findings from the Aberdeen prospective osteoporosis screening study (APOSS).中年女性的抗胆碱能负担与晚年反复跌倒:阿伯丁前瞻性骨质疏松症筛查研究(APOSS)的结果
Ther Adv Drug Saf. 2020 May 27;11:2042098620929852. doi: 10.1177/2042098620929852. eCollection 2020.
3
Anticholinergic Burden and Fractures: A Systematic Review with Methodological Appraisal.抗胆碱能负担与骨折:系统评价及方法学评估。
Drugs Aging. 2020 Dec;37(12):885-897. doi: 10.1007/s40266-020-00806-6. Epub 2020 Oct 23.
4
Anticholinergic burden is associated with recurrent and injurious falls in older individuals.抗胆碱能负担与老年人反复跌倒及跌倒致伤有关。
Maturitas. 2016 Feb;84:32-7. doi: 10.1016/j.maturitas.2015.10.009. Epub 2015 Oct 23.
5
Association of Anticholinergic Burden with Cognitive Impairment and Health Care Utilization Among a Diverse Ambulatory Older Adult Population.不同门诊老年人群中抗胆碱能负担与认知障碍及医疗保健利用的关联
Pharmacotherapy. 2016 Nov;36(11):1123-1131. doi: 10.1002/phar.1843. Epub 2016 Nov 5.
6
Low BMD is less predictive than reported falls for future limb fractures in women across Europe: results from the European Prospective Osteoporosis Study.低骨密度对欧洲女性未来肢体骨折的预测性低于报告的跌倒情况:欧洲前瞻性骨质疏松症研究结果
Bone. 2005 Mar;36(3):387-98. doi: 10.1016/j.bone.2004.11.012.
7
Association between cumulative anticholinergic burden and falls and fractures in patients with overactive bladder: US-based retrospective cohort study.累积抗胆碱能负担与膀胱过度活动症患者跌倒和骨折的关联:基于美国的回顾性队列研究。
BMJ Open. 2019 May 5;9(5):e026391. doi: 10.1136/bmjopen-2018-026391.
8
Use of Medications with Anticholinergic Properties and the Long-Term Risk of Hospitalization for Falls and Fractures in the EPIC-Norfolk Longitudinal Cohort Study.使用具有抗胆碱能特性的药物与 EPIC-Norfolk 纵向队列研究中因跌倒和骨折住院的长期风险。
Drugs Aging. 2020 Feb;37(2):105-114. doi: 10.1007/s40266-019-00731-3.
9
Frailty status and increased risk for falls: The role of anticholinergic burden.虚弱状态与跌倒风险增加:抗胆碱能负担的作用。
Arch Gerontol Geriatr. 2020 Sep-Oct;90:104136. doi: 10.1016/j.archger.2020.104136. Epub 2020 Jun 6.
10
Drugs Contributing to Anticholinergic Burden and Risk of Fall or Fall-Related Injury among Older Adults with Mild Cognitive Impairment, Dementia and Multiple Chronic Conditions: A Retrospective Cohort Study.导致轻度认知障碍、痴呆和多种慢性病的老年人抗胆碱能负担及跌倒或跌倒相关损伤风险的药物:一项回顾性队列研究
Drugs Aging. 2019 Mar;36(3):289-297. doi: 10.1007/s40266-018-00630-z.

引用本文的文献

1
The REGENERATE Study: A Non-Randomized Feasibility Study of an Intervention to REduce anticholinerGic burdEN in oldER pATiEnts.REGENERATE研究:一项关于减少老年患者抗胆碱能负担干预措施的非随机可行性研究。
Geriatrics (Basel). 2024 Nov 25;9(6):152. doi: 10.3390/geriatrics9060152.
2
Potentially inappropriate prescribing for people with dementia in ambulatory care: a cross-sectional observational study.在门诊护理中,痴呆患者潜在不适当的处方:一项横断面观察性研究。
BMC Geriatr. 2024 Apr 10;24(1):328. doi: 10.1186/s12877-024-04949-8.
3
Health-related quality of life and use of medication with anticholinergic activity in patients with multiple myeloma.
多发性骨髓瘤患者的健康相关生活质量和抗胆碱能药物的使用情况。
Support Care Cancer. 2023 Jun 6;31(7):379. doi: 10.1007/s00520-023-07835-y.
4
Anticholinergic Medication Use, Dopaminergic Genotype, and Recurrent Falls.抗胆碱能药物的使用、多巴胺能基因型与复发性跌倒。
J Gerontol A Biol Sci Med Sci. 2022 May 5;77(5):1042-1047. doi: 10.1093/gerona/glab258.
5
Anticholinergic Burden and Fractures: A Systematic Review with Methodological Appraisal.抗胆碱能负担与骨折:系统评价及方法学评估。
Drugs Aging. 2020 Dec;37(12):885-897. doi: 10.1007/s40266-020-00806-6. Epub 2020 Oct 23.
6
Quality of anticholinergic burden scales and their impact on clinical outcomes: a systematic review.抗胆碱能负担量表的质量及其对临床结局的影响:系统评价。
Eur J Clin Pharmacol. 2021 Feb;77(2):147-162. doi: 10.1007/s00228-020-02994-x. Epub 2020 Oct 3.
7
Anticholinergic burden in middle-aged women and recurrent falls in later life: findings from the Aberdeen prospective osteoporosis screening study (APOSS).中年女性的抗胆碱能负担与晚年反复跌倒:阿伯丁前瞻性骨质疏松症筛查研究(APOSS)的结果
Ther Adv Drug Saf. 2020 May 27;11:2042098620929852. doi: 10.1177/2042098620929852. eCollection 2020.
8
Use of Medications with Anticholinergic Properties and the Long-Term Risk of Hospitalization for Falls and Fractures in the EPIC-Norfolk Longitudinal Cohort Study.使用具有抗胆碱能特性的药物与 EPIC-Norfolk 纵向队列研究中因跌倒和骨折住院的长期风险。
Drugs Aging. 2020 Feb;37(2):105-114. doi: 10.1007/s40266-019-00731-3.
9
Anticholinergic burden and fractures: a protocol for a methodological systematic review and meta-analysis.抗胆碱能负担与骨折:方法学系统评价和荟萃分析方案。
BMJ Open. 2019 Aug 21;9(8):e030205. doi: 10.1136/bmjopen-2019-030205.
10
Medication in older patients reviewed multiple ways (MORE) study.老年患者用药多途径评估(MORE)研究。
Int J Clin Pharm. 2019 Oct;41(5):1262-1271. doi: 10.1007/s11096-019-00879-3. Epub 2019 Jul 13.